Tomas Mraz
Mount Sinai Hospital
16 Papers
33 Citations
Tomas Mraz is an academic researcher from Mount Sinai Hospital. The author has contributed to research in topics: Medicine & Ejection fraction. The author has an hindex of 6, co-authored 13 publications.
Chat about Author
Papers
Use of intracardiac echocardiography to guide implantation of a left atrial appendage occlusion device (PLAATO)
Ivan C.K. Ho,Petr Neuzil,Tomas Mraz,Zuzana Beldova,Dan Gross,Pavel Formánek,Milos Taborsky,Petr Niederle,Jeremy N. Ruskin,Vivek Y. Reddy +9 more
TL;DR: Using nonconventional imaging planes, ICE imaging was able to perform the intraprocedural functions provided by TEE during implantation of the PLAATO left atrial appendage occlusion device.
70
Incomplete occlusion of the left atrial appendage with the percutaneous left atrial appendage transcatheter occlusion device is not associated with increased risk of stroke
Juan F. Viles-Gonzalez,Vivek Y. Reddy,Jan Petru,Tomas Mraz,Zuzana Grossova,Stepan Kralovec,Petr Neuzil +6 more
TL;DR: The main finding of this analysis suggests that in long-term follow-up, residual flow after LAA occlusion with the PLAATO device, as documented by cardiac CT, is ubiquitous but is not associated with an increased risk of stroke.
53
Left Atrial Appendage Closure in Patients With Contraindications to Oral Anticoagulation
Dinesh Sharma,Vivek Y. Reddy,Marcus Sandri,Philipp Schulz,Nicolas Majunke,Pavel Hala,Jens Wiebe,Tomas Mraz,Marc A. Miller,Petr Neuzil,Sven Möbius-Winkler,Horst Sievert,Peter Sick +12 more
TL;DR: The PROTECT AF (Watchman Left Atrial Appendage Closure Technology for Embolic Protection in Patients With Atrial Fibrillation) and PREVAIL (Prospective Randomized Evaluation of the Watchman LAA Closure Device) trials revealed.
36
Role of echocardiography in percutaneous occlusion of the left atrial appendage.
TL;DR: TEE represents a more convenient approach in patients who are not under generally anesthesia and helps to facilitate transseptal puncture and TEE, having the ability to rotate the image plane, helps to better determine the position of the occluder.
34
Pacemaker‐Mediated Programmable Hypertension Control Therapy
Petr Neuzil,Béla Merkely,Andrejs Erglis,Germanas Marinskis,Joris R. de Groot,Herwig Schmidinger,Manuel Rodriguez Venegas,Michiel Voskuil,Thomas Sturmberger,Jan Petru,Niels Jongejan,Josef Aichinger,Ginta Kamzola,Audrius Aidietis,László Gellér,Tomas Mraz,István Osztheimer,Yuval Mika,Steven J. Evans,Daniel Burkhoff,Karl-Heinz Kuck,BackBeat Study Investigators +21 more
TL;DR: Initial indications are that this therapy is a safe and promising therapy for such patients with persistent hypertension despite medical therapy, and oSBP and 24‐hour ambulatory systolic blood pressure are decreased by PHC therapy.
25